Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Expert Video Report on hematologic aspects of the Covid 19 pandemic from ASH 2020

Reporting from the 62nd ASH Annual Meeting, Eleni Gavriilaki comments on studies highlighting the hematologic aspect of the COVID-19 pandemic. She details findings about thrombotic microangiopathy variants independantly associated with critical COVID-19 which may help identify patients who could benefit from targeted therapy. She also presents results about the outcome of patients presenting with hematologic malignancy and COVID-19, and explains how allogenic Sars-Cov-2 specific T cells from recovering individuals have been used to treat high risk patients with COVID-19.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.